Work

Supplementary Tables S1-S3 from Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Tables shows primary antibodies used for Western blot, IHC, Flow Cytometry and IC50 values for Uro A.

DOI: 10.1158/1535-7163.22507756

Authors: Tulasigeri M. Totiger, Supriya Srinivasan, Venkatakrishna R. Jala, Purushottam Lamichhane, Austin R. Dosch, Alexander A. Gaidarski, Chandrashekhar Joshi, Shobith Rangappa, Jason Castellanos, Praveen Kumar Vemula, Xi Chen, Deukwoo Kwon, Nilesh Kashikar, Michael VanSaun, Nipun B. Merchant, Nagaraj S. Nagathihalli

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362494070

Cites:

Cited by:

Related to: 10